While losing fat is the goal for many, losing muscle mass is a serious concern, especially when it comes to long-term health and weight management
Ella lo recomend con una dosis muy baja y despus la fuimos aumentando hasta 1 mg
Five of the articles reviewed showed that there was no significant difference between GLP-1 groups and control groups
The 228th ACS National Meeting, Philadelphia, PA, August 24, 2004
It will be important for clinicians caring for those with T2D and different manifestations of ASCVD, including but not limited to MI and ischemic stroke, to consider or advise the use of GLP-1 RAs in appropriate patients to reduce future CV events
Narrow-therapeutic-index drugs Drugs where small changes in plasma concentration produce either toxicity or therapeutic failure are the most clinically significant: Warfarin